South San Francisco, CA, United States of America

Liqin Xie

This inventor holds 1 USPTO granted patent. Top assignee: Surrozen Operating, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liqin Xie. Retrieved from https://idiyas.com/inventor/liqin-xie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Liqin Xie

Introduction

Liqin Xie is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods for treating diseases. Her work focuses on the Wnt signaling pathway, which plays a crucial role in various biological processes.

Latest Patents

Liqin Xie holds a patent for "WNT surrogate molecules and uses thereof." This invention provides Wnt pathway agonists and related compositions, which may be utilized in a variety of therapeutic methods for the treatment of diseases. She has 1 patent to her name, showcasing her innovative approach to addressing complex health issues.

Career Highlights

Liqin Xie is currently employed at Surrozen Operating, Inc., a company dedicated to advancing therapeutic solutions through innovative research. Her role at Surrozen allows her to collaborate with other talented professionals in the field, contributing to groundbreaking advancements in biotechnology.

Collaborations

Some of her notable coworkers include Yang Li and Tom Zhiye Yuan. Together, they work on various projects that aim to enhance the understanding and application of Wnt pathway research.

Conclusion

Liqin Xie's contributions to biotechnology and her innovative patent work highlight her as a key figure in the field. Her dedication to developing therapeutic methods demonstrates the impact of her research on improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…